151 related articles for article (PubMed ID: 31914633)
1. Fam20C-mediated phosphorylation of osteopontin is critical for its secretion but dispensable for its action as a cytokine in the activation of hepatic stellate cells in liver fibrogenesis.
Tibaldi E; Brocca A; Sticca A; Gola E; Pizzi M; Bordin L; Pagano MA; Mazzorana M; Donà G; Violi P; Marin O; Romano A; Angeli P; Carraro A; Brunati AM
FASEB J; 2020 Jan; 34(1):1122-1135. PubMed ID: 31914633
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin α(V)β(3) engagement and PI3K/pAkt/NFκB signaling.
Urtasun R; Lopategi A; George J; Leung TM; Lu Y; Wang X; Ge X; Fiel MI; Nieto N
Hepatology; 2012 Feb; 55(2):594-608. PubMed ID: 21953216
[TBL] [Abstract][Full Text] [Related]
3. Osteopontin is an important mediator of alcoholic liver disease via hepatic stellate cell activation.
Seth D; Duly A; Kuo PC; McCaughan GW; Haber PS
World J Gastroenterol; 2014 Sep; 20(36):13088-104. PubMed ID: 25278703
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
5. Coordinated signaling of activating transcription factor 6α and inositol-requiring enzyme 1α regulates hepatic stellate cell-mediated fibrogenesis in mice.
Xue F; Lu J; Buchl SC; Sun L; Shah VH; Malhi H; Maiers JL
Am J Physiol Gastrointest Liver Physiol; 2021 May; 320(5):G864-G879. PubMed ID: 33728997
[TBL] [Abstract][Full Text] [Related]
6. Thrombin cleavage of osteopontin controls activation of hepatic stellate cells and is essential for liver fibrogenesis.
Cui G; Chen J; Wu Z; Huang H; Wang L; Liang Y; Zeng P; Yang J; Uede T; Diao H
J Cell Physiol; 2019 Jun; 234(6):8988-8997. PubMed ID: 30350863
[TBL] [Abstract][Full Text] [Related]
7. Signalling via the osteopontin and high mobility group box-1 axis drives the fibrogenic response to liver injury.
Arriazu E; Ge X; Leung TM; Magdaleno F; Lopategi A; Lu Y; Kitamura N; Urtasun R; Theise N; Antoine DJ; Nieto N
Gut; 2017 Jun; 66(6):1123-1137. PubMed ID: 26818617
[TBL] [Abstract][Full Text] [Related]
8. Ras-transformation reduce FAM20C expression and osteopontin phosphorylation.
Schytte GN; Christensen B; Bregenov I; Sørensen ES
Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32830861
[TBL] [Abstract][Full Text] [Related]
9. Osteopontin delays resolution of liver fibrosis.
Leung TM; Wang X; Kitamura N; Fiel MI; Nieto N
Lab Invest; 2013 Oct; 93(10):1082-9. PubMed ID: 23999249
[TBL] [Abstract][Full Text] [Related]
10. Fam20C Regulates Bone Resorption and Breast Cancer Bone Metastasis through Osteopontin and BMP4.
Zuo H; Yang D; Wan Y
Cancer Res; 2021 Oct; 81(20):5242-5254. PubMed ID: 34433585
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin is a proximal effector of leptin-mediated non-alcoholic steatohepatitis (NASH) fibrosis.
Coombes JD; Choi SS; Swiderska-Syn M; Manka P; Reid DT; Palma E; Briones-Orta MA; Xie G; Younis R; Kitamura N; Della Peruta M; Bitencourt S; Dollé L; Oo YH; Mi Z; Kuo PC; Williams R; Chokshi S; Canbay A; Claridge LC; Eksteen B; Diehl AM; Syn WK
Biochim Biophys Acta; 2016 Jan; 1862(1):135-44. PubMed ID: 26529285
[TBL] [Abstract][Full Text] [Related]
12. NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease.
Syn WK; Agboola KM; Swiderska M; Michelotti GA; Liaskou E; Pang H; Xie G; Philips G; Chan IS; Karaca GF; Pereira Tde A; Chen Y; Mi Z; Kuo PC; Choi SS; Guy CD; Abdelmalek MF; Diehl AM
Gut; 2012 Sep; 61(9):1323-9. PubMed ID: 22427237
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of GSK-3β induces AP-1-mediated osteopontin expression to promote cholestatic liver fibrosis.
Zhuang S; Hua X; He K; Zhou T; Zhang J; Wu H; Ma X; Xia Q; Zhang J
FASEB J; 2018 Aug; 32(8):4494-4503. PubMed ID: 29529390
[TBL] [Abstract][Full Text] [Related]
14. ECM1 Prevents Activation of Transforming Growth Factor β, Hepatic Stellate Cells, and Fibrogenesis in Mice.
Fan W; Liu T; Chen W; Hammad S; Longerich T; Hausser I; Fu Y; Li N; He Y; Liu C; Zhang Y; Lian Q; Zhao X; Yan C; Li L; Yi C; Ling Z; Ma L; Zhao X; Xu H; Wang P; Cong M; You H; Liu Z; Wang Y; Chen J; Li D; Hui L; Dooley S; Hou J; Jia J; Sun B
Gastroenterology; 2019 Nov; 157(5):1352-1367.e13. PubMed ID: 31362006
[TBL] [Abstract][Full Text] [Related]
15. Significance of MR/OPN/HMGB1 axis in NAFLD-associated hepatic fibrogenesis.
Tang M; Jia H; Chen S; Yang B; Patpur BK; Song W; Chang Y; Li J; Yang C
Life Sci; 2021 Jan; 264():118619. PubMed ID: 33091447
[TBL] [Abstract][Full Text] [Related]
16. Osteopontin - A potential biomarker of advanced liver disease.
Bruha R; Vitek L; Smid V
Ann Hepatol; 2020; 19(4):344-352. PubMed ID: 32005637
[TBL] [Abstract][Full Text] [Related]
17. Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni.
Pereira TA; Syn WK; Machado MV; Vidigal PV; Resende V; Voieta I; Xie G; Otoni A; Souza MM; Santos ET; Chan IS; Trindade GV; Choi SS; Witek RP; Pereira FE; Secor WE; Andrade ZA; Lambertucci JR; Diehl AM
Clin Sci (Lond); 2015 Nov; 129(10):875-83. PubMed ID: 26201095
[TBL] [Abstract][Full Text] [Related]
18. PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.
Grouix B; Sarra-Bournet F; Leduc M; Simard JC; Hince K; Geerts L; Blais A; Gervais L; Laverdure A; Felton A; Richard J; Ouboudinar J; Gagnon W; Leblond FA; Laurin P; Gagnon L
J Pharmacol Exp Ther; 2018 Oct; 367(1):71-81. PubMed ID: 30093459
[TBL] [Abstract][Full Text] [Related]
19. Osteopontin induces ductular reaction contributing to liver fibrosis.
Wang X; Lopategi A; Ge X; Lu Y; Kitamura N; Urtasun R; Leung TM; Fiel MI; Nieto N
Gut; 2014 Nov; 63(11):1805-18. PubMed ID: 24496779
[TBL] [Abstract][Full Text] [Related]
20. Liuweiwuling tablets attenuate BDL-induced hepatic fibrosis via modulation of TGF-β/Smad and NF-κB signaling pathways.
Liu H; Dong F; Li G; Niu M; Zhang C; Han Y; He L; Yin P; Wang B; Sang X; Li R; Wang J; Bai Z; Xiao X
J Ethnopharmacol; 2018 Jan; 210():232-241. PubMed ID: 28864168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
